The
Global API (Active Pharmaceutical Ingredient) Intermediate
Market is expected to grow at a
substantial CAGR in the years to come. API intermediates are those agents that
are extensively employed as raw materials in the preparation of active
pharmaceutical ingredients. Other technologies that are also considered while carrying
out the production of these intermediates may entail alkoxylation,
hydroformlylation, phosgene chemistry, electrochemisty, amination,
hydrogenation, and acetylene chemistry. These compounds are also known as
Active Pharmaceutical Ingredient Intermediates in the elongated form. The
product is gaining huge recognition due to rising scope and applications across
the globe.
The
factors that are responsible for the robust market growth may include mounting
investments by the leading manufacturers, increasing industrialization,
urbanization, augmented awareness among the end users, technological
advancements in production of API, increasing occurrences of chronic diseases,
rise in the prevalence of cancer, mounting significance of generics, and rapid
rise in the geriatric population.
Global
API (Active Pharmaceutical Ingredient) Intermediate Market is segmented on the
basis of product as Chemical Intermediates, Biotech Intermediates, and others.
The factors that are hampering the market growth may include implementation of
strict regulations and unsuitable drug cost control policies across various
nations. It has been anticipated that the API (Active Pharmaceutical
Ingredient) Intermediate Market will witness a huge upsurge in the next couple
of years due to rising applications and scope across the globe.
Active
Pharmaceutical Ingredient Intermediate Market is segmented on the basis of type
as Generic APIs, Innovative, and others. API (Active Pharmaceutical Ingredient)
Intermediate Market is segmented on the basis of type of synthesis as
Synthetic, Biotech APIs, and others. API (Active Pharmaceutical Ingredient)
Intermediate Market is segmented on the basis of type of intermediate as
Non-patent Intermediates, Patent Intermediates, and others. API (Active
Pharmaceutical Ingredient) Intermediate Market is segmented on the basis of
application as Endocrinology, CNS & Neurological Disorders, Oncology,
Diabetes, Cardiovascular Disease, and others. API (Active Pharmaceutical
Ingredient) Intermediate Market is segmented on the basis of geography as North
America, Southeast Asia, China, Europe, Japan, and India.
Among
all the geographical regions, North America is currently recognized as the
leader of the market and it is simultaneously registering for the largest share
in the market, the reason being mounting demands for biologics and specialty
drugs, rise in the number of chronic diseases, augmentation in the focus of the
government authorities on the rising adoption of generic drugs, technological
advancement in the production of API, and augmented demands across various
sectors. United States is recognized as the prominent contributor to the market
growth.
In
contrast, it is likely that Asia Pacific and Europe will come up as one of the
promising regions owing to coming up of various leading companies and
developing opportunities in these regions. The prominent players operating in
the API (Active Pharmaceutical Ingredient) Intermediate Market are recognized
as Hipharma Limited, BASF, Cambrex Corporation, Sanofi Winthrop Industrie S.A.,
Shandong Jiulong Fine Chemical Co., Ltd., AMPAC Fine Chemicals, and Jigs
Chemical.
Comments
Post a Comment